Biomoda Inc., of Albuquerque, N.M., elected Albert Goodman to its board.

BioServe, of Beltsville, Md., appointed Kevin Krenitsky CEO.

The Biotechnology Industry Organization, of Washington, elected Joshua Boger chairman of the board.

Canaccord Adams, of Boston, added two investment bankers from ThinkEquity Partners to its life sciences team: David Strupp and Michael Rice, both as managing directors to be based in New York.

CellCyte Genetics Corp., of Kirkland, Wash., appointed Nathan McDonald vice president of finance.

Chemokine Therapeutics Corp., of Vancouver, British Columbia, said Anthony Tolcher joined its oncology clinical advisory board.

Cowen Group Inc., of New York, hired Jean-Yves Coste as director to lead its European life science business. He will based in London.

DOV Pharmaceutical Inc., of Somerset, N.J., elected Joseph Zakrzewski to its board.

ExonHit Therapeutics SA, of Paris, appointed Deborah Smeltzer to its supervisory board.

Favrille Inc., of San Diego, appointed Richard Ghalie chief medical officer.

Gilead Sciences Inc., of Foster City, Calif., promoted Paul Carter to senior vice president, international commercial operations.

ImClone Systems Inc., of New York, appointed Jules Haimovitz as a director.

InNexus Biotechnology Inc., of Vancouver, British Columbia, added Thomas Kindt to its scientific advisory board.

Inovio Biomedical Corp., of San Diego, elected Bob Rieder to its board.

Insight Medical Group, of Oxford, Miss., appointed Kary Mullis to its board of advisors.

Interface Biologics Inc., of Toronto, added Robert Schwartz to its advisory board.

La Jolla Pharmaceutical Co., of San Diego, hired Niv Caviar as executive vice president, chief business officer and chief financial officer.

MDS Pharma Services, of King of Prussia, Pa., appointed James Pusey vice president and general manager of its global clinical development business.

Mersana Therapeutics, of Cambridge, Mass., appointed Robert Fram to the newly created position of chief medical officer.

Pharmacopeia Drug Discovery Inc., of Princeton, N.J., elected Martin Soeters and Dennis Langer to its board.

Pharmacyclics Inc., of Sunnyvale, Calif., appointed Michael Inouye senior vice president of corporate and commercial development.

Poniard Pharmaceuticals Inc., of South San Francisco, appointed Ronald Martell president and chief operating officer. It also appointed Robert Basso to its board.

ProEthic Pharmaceuticals Inc., of Montgomery, Ala., appointed James Lattanzi chief financial officer.